Ready to play
Ready to play
Egypt is facing a shortage of essential medications, particularly drugs for chronic illnesses and cancer, ahead of the winter season. The limited availability of these medicines adds an extra burden on patients. The Egyptian Center for the Right to Medicine confirmed that the ongoing shortage poses a threat to patients' rights to access appropriate medications quickly and at an affordable cost. It pointed out that current measures, such as adjusting the prices of around 4,000 drug varieties in 2023, are insufficient to address the problem fundamentally. The center called for the issuance of periodic bulletins listing the missing medicines and for achieving a balance between ensuring a sustainable pharmaceutical industry and maintaining the population's ability to afford medicines. The report also noted that the crisis extends to government hospitals and the national health insurance system. Despite Egypt's progress in localizing and expanding its pharmaceutical manufacturing, the drug shortage continues to impact treatments for cancers, heart diseases, and immune disorders, increasing patients' suffering amid rising costs and making it difficult to distinguish between original and generic medicines.
Notice: This Is an AI-Generated Summary
Comments (0)